AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2021
Oct 18, 2021
35460_dirs_2021-10-18_d1d74cab-2692-4361-8821-d1a31387db00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2021-09-16
Reporting Person: Hagel Jillian Marie (Chief Technical Officer)
More from Enveric Biosciences, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23